Tetanus, Diphtheria, Hib, Meningococcal, Pertussis
Vaccine
| MENVEO® - by Novartis |
|
Meningococcal Diphtheria Conjugate Vaccine |
|
|
MENVEO® is a vaccine indicated for active immunization to prevent invasive meningococcal
disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.
MENVEO® is approved for use in persons 2 through 55 years of age.
MENVEO® does not prevent N. meningitidis serogroup B infections.
For indications, dosing and other information, please refer to the
prescribing information.
|
 |
|
|
| Product |
Size |
NDC Number |
|
|
|
|
MENVEO® |
5 pack |
46028-208-01 |
PI |
MSDS |
|
|
|
| |
|
For questions or additional information regarding
clinical pharmacology, indications, contraindications and uses,
product warnings, precautions, adverse reactions, dosage,
administration and/or storage of a specified product please contact BDI Pharma or call
1-800-948-9834. |
| |
|
| |
|
| |
|
| |
|
| |
|